On Tuesday, CFRA, a prominent financial research firm, updated its outlook on Morgan Stanley (NYSE:MS), raising the stock's price target from $97.00 to $108.00, while reaffirming a Buy rating. The adjustment reflects the firm's positive view on Morgan Stanley's potential to gain from a nascent recovery in the sectors of investment banking and asset management.
The analyst at CFRA cited several reasons for the optimistic stance, including expectations that underwriting and advisory fees will increase as CEOs look to renew capital formation. Additionally, alternative investment firms are anticipated to monetize assets later in the year to meet commitments to their limited partners.
This outlook is supported by an increase in the firm's earnings per share (EPS) estimates for 2024 and 2025, to $7.10 and $7.75 respectively, up from previous forecasts of $6.60 and $7.20.
Morgan Stanley's recent financial performance also underpins CFRA's revised price target. The company reported a first-quarter EPS of $2.02, surpassing expectations by $0.37. Notably, the Institutional Securities division saw a 113% year-over-year increase in equity underwriting and a 37% rise in debt underwriting.
Despite a 28% decline in mergers and acquisitions (M&A), CFRA remains confident in a robust reversal in the upcoming quarters.
The firm's Wealth Management and Investment Management units also demonstrated growth, with revenues climbing 5% and 7% year-over-year, respectively. Equity trading revenues increased by 4%, while fixed income, currencies, and commodities (FICC) trading saw a 4% decrease.
Geographically, America's revenues grew by 7% year-over-year, contributing to 76% of the total, while the EMEA region saw a 5% increase, and Asia experienced a 12% decline.
CFRA's revised revenue forecasts for Morgan Stanley stand at $59.8 billion for 2024 and $63.0 billion for 2025. These projections, alongside the recent financial results, reinforce the firm's belief in Morgan Stanley's growth trajectory and justify the raised price target based on a forward price-to-earnings (P/E) ratio of 15.2x, which is above the three-year historical average of 13.6x.
InvestingPro Insights
As Morgan Stanley (NYSE:MS) continues to navigate the financial landscape, recent analysis from InvestingPro offers valuable insights. With a market capitalization adjusted to $145.99 billion, the company's P/E ratio stands at a solid 17.23, reflecting investor confidence in its earnings potential.
More precisely, the adjusted P/E ratio for the last twelve months as of Q4 2023 is 16.2, indicating a slight discount compared to the current P/E.
An InvestingPro Tip highlights Morgan Stanley's impressive track record of raising its dividend for 10 consecutive years, showcasing a commitment to shareholder returns. This is further evidenced by the company maintaining dividend payments for over three decades. Additionally, the firm's liquid assets exceed its short-term obligations, providing financial stability and resilience.
InvestingPro also notes that analysts predict Morgan Stanley will be profitable this year, a sentiment backed by the company's profitability over the last twelve months. With a strong return over the past five years, Morgan Stanley stands out as a prominent player in the Capital Markets industry.
For readers interested in further insights and tips, InvestingPro offers additional guidance on Morgan Stanley. Use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and discover more than 9 additional InvestingPro Tips to inform your investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.